These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15459599)

  • 1. Cytomegalovirus and Chlamydia pneumoniae as predictors for adverse events and angina pectoris after percutaneous coronary intervention.
    Rahel BM; Visseren FL; Suttorp MJ; Plokker TH; Kelder JC; de Jongh BM; Diepersloot RJ; Verkooyen RP; Bouter KP
    Am Heart J; 2004 Oct; 148(4):670-5. PubMed ID: 15459599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic markers of persistent Chlamydia pneumonia infection and long-term prognosis after successful coronary stenting.
    Zairis MN; Papadaki OA; Psarogianni PK; Thoma MA; Andrikopoulos GK; Batika PC; Poulopoulou CG; Trifinopoulou KG; Olympios CD; Foussas SG
    Am Heart J; 2003 Dec; 146(6):1082-9. PubMed ID: 14661003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age.
    Gattone M; Iacoviello L; Colombo M; Castelnuovo AD; Soffiantino F; Gramoni A; Picco D; Benedetta M; Giannuzzi P
    Am Heart J; 2001 Oct; 142(4):633-40. PubMed ID: 11579353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous angioplasty of chronically occluded coronary arteries: long-term clinical follow-up.
    Drozd J; Wójcik J; Opalińska E; Zapolski T; Widomska-Czekajska T
    Kardiol Pol; 2006 Jul; 64(7):667-73; discussion 674. PubMed ID: 16886123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month outcomes after single- and multi-lesion percutaneous coronary intervention: results from the ROSETTA registry.
    Goldman LE; Okrainec K; Eisenberg MJ; Schechter D; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Del Core M; Duerr R; Huynh T; Smilovitch M; Sedlis S; Brown DL; Brieger D;
    Can J Cardiol; 2004 May; 20(6):608-12. PubMed ID: 15152290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
    Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
    Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
    Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA
    Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy.
    Arampatzis CA; Goedhart D; Serruys PW; Saia F; Lemos PA; de Feyter P;
    Am Heart J; 2005 Feb; 149(2):329-35. PubMed ID: 15846273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts.
    Upadhya B; Applegate RJ; Sane DC; Deliargyris EN; Kutcher MA; Gandhi SK; Baki TT; Call JT; Little WC
    Am J Cardiol; 2005 Aug; 96(4):515-8. PubMed ID: 16098303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual high-grade angina after enhanced external counterpulsation therapy.
    McCullough PA; Henry TD; Kennard ED; Kelsey SF; Michaels AD;
    Cardiovasc Revasc Med; 2007; 8(3):161-5. PubMed ID: 17765644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mid-term symptom recurrence, adverse cardiac events and mortality in 591 unselected off-pump coronary artery bypass graft patients.
    Gurbuz AT; Zia AA; Cui H; Sasmazel A; Ates G; Aytac A
    J Card Surg; 2006; 21(1):28-34. PubMed ID: 16426344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of infarction-related artery occlusion and multivessel disease in postinfarction angina.
    Valenzuela LF; Vázquez R; Fournier JA; Cubero J; Maraví J; Cruz-Fernández JM; Kaski JC
    Int J Cardiol; 2007 Feb; 115(3):381-5. PubMed ID: 16814417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
    Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D
    Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes.
    Glaser R; Selzer F; Jacobs AK; Laskey WK; Kelsey SF; Holper EM; Cohen HA; Abbott JD; Wilensky RL
    Am J Cardiol; 2006 Dec; 98(11):1446-50. PubMed ID: 17126647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the correlation of between infection, inflammation and coronary artery disease].
    Cai XJ; Cai HB; Lu D
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jun; 24(6):503-7. PubMed ID: 12848920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).
    Rodriguez AE; Baldi J; Fernández Pereira C; Navia J; Rodriguez Alemparte M; Delacasa A; Vigo F; Vogel D; O'Neill W; Palacios IF;
    J Am Coll Cardiol; 2005 Aug; 46(4):582-8. PubMed ID: 16098419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chlamydia antibody titers in patients with coronary disease: relations to age and clinical stage].
    el-Rabadi K; Gottsauner-Wolf M; Christ G; Maurer G; Huber K
    Wien Klin Wochenschr; 2001 Oct; 113(19):727-30. PubMed ID: 11715750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.